Saudi Central Bank’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$27.3M Buy
29,661
+29,328
+8,807% +$29.7M 0.58% 43
2025
Q4
$358K Hold
333
0.01% 49
2025
Q3
$254K Buy
333
+2
+0.6% +$1.49K 0.01% 51
2025
Q2
$258K Buy
331
+13
+4% +$10.1K 0.01% 53
2025
Q1
$263K Buy
+318
New +$265K 1.39% 12

Other funds holding LLY

Saudi Central Bank's LLY Position: Q1 2026 in Review

Saudi Central Bank increased its Eli Lilly (LLY) stake by 8,807% in Q1 2026, buying an estimated $29.7M and bringing the position to 29,661 shares worth $27.3M. The position accounts for 0.58% of the portfolio, ranked #43.

Saudi Central Bank first reported a position in LLY in Q1 2025 and has held it in 5 quarters since. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Saudi Central Bank held 29,661 shares of Eli Lilly worth $27.3M as of Q1 2026.
  • Saudi Central Bank bought 29,328 Eli Lilly shares in Q1 2026, an estimated $29.7M.
  • Eli Lilly made up 0.58% of Saudi Central Bank's portfolio in Q1 2026, its #43 holding.
  • Saudi Central Bank first reported a position in Eli Lilly in Q1 2025 and has held it in 5 quarters since.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Saudi Central Bank's 13F filing for Q1 2026, filed 15 May 2026.